A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors

NCT07250386 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

NSCLC (Advanced Non-small Cell Lung Cancer)
Breast Cancer

Interventions

BIOLOGICAL: CEA-targeted CAR-T (Intravenous)
BIOLOGICAL: CEA-targeted CAR-T (Intrapleural)

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]